NeuroPace (NPCE) Liabilities and Shareholders Equity (2020 - 2026)

NeuroPace has reported Liabilities and Shareholders Equity for 7 years, with the latest figure at $98.9 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 10.26% year-over-year to $98.9 million; the trailing twelve-month figure through Mar 2026 stood at $417.8 million (up 5.63% YoY), and the FY2025 full-year result was $105.6 million, up 11.54% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $98.9 million, down from $105.6 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $129.0 million in Q1 2022, with the low at $94.4 million in Q2 2024.
• Average Liabilities and Shareholders Equity over 5 years is $106.5 million, with a median of $106.1 million recorded in 2025.
• Peak annual rise in Liabilities and Shareholders Equity reached 156.3% in 2022, while the deepest fall reached 19.34% in 2022.
• Tracing NPCE's Liabilities and Shareholders Equity over 5 years: stood at $114.1 million in 2022, then dropped by 5.66% to $107.7 million in 2023, then retreated by 12.08% to $94.6 million in 2024, then rose by 11.54% to $105.6 million in 2025, then fell by 6.32% to $98.9 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $98.9 million (Q1 2026), $105.6 million (Q4 2025), and $107.3 million (Q3 2025), per Business Quant data.

Peer Comparison